Xometry Q2 revenue up 23%, beats analyst expectations

Reuters
08/05
Xometry <a href="https://laohu8.com/S/QTWO">Q2</a> revenue up 23%, beats analyst expectations

Overview

  • Xometry Q2 revenue rises 23% yr/yr, beating analyst expectations, per LSEG data

  • Adjusted EPS for Q2 beats estimates

  • Adjusted EBITDA improves significantly, driven by marketplace gross margin expansion

Outlook

  • Xometry sees Q3 revenue of $167-$169 mln, 18-19% growth y-o-y

  • Company expects Q3 adjusted EBITDA of $4.0-$5.0 mln

  • Xometry raises FY 2025 marketplace growth outlook to 23-24%

  • Company expects FY 2025 supplier services revenue down ~5% y-o-y

Result Drivers

  • MARKETPLACE GROWTH - Q2 revenue driven by robust marketplace growth, with marketplace revenue up 26% yr/yr

  • ENTERPRISE EXPANSION - Strong enterprise growth and expanding networks of buyers and suppliers boosted marketplace revenue

  • GROSS MARGIN EXPANSION - Record marketplace gross margin of 35.4% contributed to increased gross profit

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Beat

$162.55 mln

$156.60 mln (10 Analysts)

Q2 Adjusted EPS

Beat

$0.09

$0.04 (9 Analysts)

Q2 Adjusted Net Income

$4.68 mln

Q2 Net Income

-$26.43 mln

Q2 Adjusted EBITDA

Beat

$3.93 mln

$1.61 mln (8 Analysts)

Q2 Gross Profit

$65.18 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", 2 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the it services & consulting peer group is "buy"

  • Wall Street's median 12-month price target for Xometry Inc is $35.50, about 12.8% above its August 4 closing price of $30.97

  • The stock recently traded at 64 times the next 12-month earnings vs. a P/E of 77 three months ago

Press Release: ID:nGNX1dgmND

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10